Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP Patients
Status:
Not yet recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
Elderly ITP patients have many underlying diseases, hormone contraindications and many
adverse reactions during the use of hormones. TPO-RAs are oral small-molecule non-peptide
drugs. Retrospective studies have shown that they have good efficacy and high safety in
elderly patients. Therefore, this study is a prospective trial to evaluate TPO-RAs as the
first-choice drug for the treatment of elderly ITP patients with contraindications to
hormones, aiming to improve the efficacy-risk ratio of elderly patients